HCA Healthcare, Inc. (HCA) operating KPIs
HCANYSEServices-General Medical & Surgical Hospitals, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 10/301% below fair value
$473.19−4.89 (-1.02%)
Close on Oct 30, 2026Market cap $102.45BP/E 15.7Yield 0.61%
HCA Healthcare methicillin-Resistant Staphylococcus Aureus (MRSA) — National Percentile Ranking (×)
Annual figures from HCA Healthcare's filings and investor materials
Latest, FY2025
57.20
Period ended Dec 31, 2025
Change on a year earlier
+15.8%
49.40 in FY2024
History
3 years
Since FY2022
Sources
3
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Methicillin-Resistant Staphylococcus Aureus (MRSA) — National Percentile Ranking (×) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 57.20 | +15.8% | HCA Healthcare DEF 14A Proxy (2026-03-13) ↗ |
| FY2024 | Dec 31, 2024 | 49.40 | – | HCA Healthcare DEF 14A Proxy (2025-03-14) ↗ |
| FY2022 | Dec 31, 2022 | 63.90 | – | HCA Healthcare DEF 14A Proxy (2023-03-10) ↗ |
Cite this data
StockData. (2026). HCA Healthcare Methicillin-Resistant Staphylococcus Aureus (MRSA) — National Percentile Ranking (×), annual FY2022–FY2025 [Data set]. Compiled from HCA Healthcare SEC filings and investor materials. https://stockdatahq.com/stocks/hca/kpis/qual_mrsa
See every metric in the HCA Healthcare KPI table. Data updated Oct 29, 2026.